Drugmaker to testify on why weight-loss drugs cost 15x more in the US
Enlarge / Lars Fruergaard Jorgensen, chief executive officer Novo Nordisk A/S, during an interview at the company's headquarters in Bagsvaerd,...
Enlarge / Lars Fruergaard Jorgensen, chief executive officer Novo Nordisk A/S, during an interview at the company's headquarters in Bagsvaerd,...
The breakthrough in weight-loss drugs has shaken the healthcare industry. Goldman Sachs Research expects weight-loss drugs to boost U.S. gross...